search
Bioiberica
Trends
- 1Bioiberica targets longevity and GLP-1 ahead of CPHI Milan 2026▼CPHI Milan 2026: Bioiberica eyes longevity and GLP-1 as healthy aging becomes targeted
Spanish ingredients maker Bioiberica says it will focus on longevity science and GLP-1 companion products at CPHI Milan 2026, positioning its portfolio around targeted healthy aging solutions. The announcement reflects a wider industry shift as supplement and pharmaceutical ingredient suppliers move from general wellness claims toward condition-specific, age-related health products tied to the surge in GLP-1 drug use.